TABLE 1.
Study | Year | Medication | Sample Size | Design | Length of Treatment | Mean Age | Gender (% Male) | JADAD Score | Mean Dose (mg/d) |
---|---|---|---|---|---|---|---|---|---|
Gordon et al46 | 1993 | Clomipramine (TCA) | 12 | Crossover | 5 wk | 10.4 y | 57 | 3 | 152 |
McDougle et al47 | 1996 | Fluvoxamine (SSRI) | 30 | Parallel | 12 wk | 30.1 y | 90 | 4 | 277 |
Remington et al48 | 2001 | Clomipramine (TCA) | 36 | Crossover | 7 wk | 16.4 y | 83 | 3 | 128 |
Hollander et al49 | 2005 | Fluoxetine (SSRI) | 39 | Crossover | 8 wk | 8.2 y | 77 | 3 | 10.6 |
King et al50 | 2009 | Citalopram (SSRI) | 149 | Parallel | 12 wk | 9.4 y | 86 | 5 | 16.5 |
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders,a NCT0060953135 | Active, not recruiting | Citalopram (SSRI) | 13 | Parallel | 12 wk | 22 y | Information not provided | 3 | 18.3 |
McDougle et al,b unpublished52 | Completed | Fluvoxamine (SSRI) | 34 | Parallel | 12 wk | 5–18 | 85 | UK | 106.9 |
Study of Fluoxetine in Autism (SOFIA),b NCT0051532043 | Completed 1/09 | Fluoxetine (SSRI) | 158 | Parallel | 14 wk | 5–17 y | UK | UK | UK |
Study of Fluoxetine in Adults With Autistic Disorder,b NCT0002740444 | Completed 10/05 | Fluoxetine (SSRI) | 48 | Parallel | 12 wk | 18–65 y | UK | UK | UK |
Fluvoxamine and Sertraline in Childhood Autism – Does SSRI Therapy Improve Behaviour and/or Mood?b NCT0065517445 | Completed 1/07 | Fluvoxamine (SSRI) | 108 | Parallel | Children were started on 12.5 mg. If no therapeutic effectiveness was observed after 8 wks, then the child’s dosage could be increased for an additional 8 wk | 3–10 y | UK | UK | 12.5 |
Effectiveness of Early Intervention With Fluoxetine in Enhancing Developmental Processes in Children With Autism,b NCT0018333946 | Completed 2/08 | Fluoxetine (SSRI) | 19 | Parallel | 12 mo | 30–58 mo | UK | UK | 2–20 |
SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; UK, unknown.
We received trial data in response to our request for relevant data for this trial only.
Studies completed but unpublished. Requests were sent to the principal investigators for data associated with each of these trials.